Overall, understanding how IL-6 transmits signals to affect lipid metabolism in the heart might allow for development of better clinical therapies for obesity-associated cardiac lipotoxicity. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.